Department of Dermatology

Yuri Bunimovich, MD, PhD

  • Assistant Professor

Yuri Bunimovich, MD, PhD, is an Assistant Professor who joined the Department of Dermatology in 2015, after completing his dermatology residency training at the University of Pittsburgh.  

Prior to joining the Department of Dermatology, Dr. Bunimovich received his medical degree from the University of Buffalo, School of Medicine and Biomedical Sciences, and completed his PhD in Chemistry and Chemical Engineering, at the California Institute of Technology.  He completed his postdoctoral fellowship in molecular and medical pharmacology at the California NanoSystems Institute in Los Angeles, California. 

Dr. Bunimovich practices general medical and surgical dermatology, including treatment of diseases such as atopic dermatitis, psoriasis, autoimmune, and immunobullous conditions. He also has a special interest in cutaneous malignancies, both melanoma and non-melanoma skin cancers.  


Professional Memberships

  • American Academy of Dermatology

  • Society of Investigative Dermatology

  • American Cancer Society

  • American Society of Dermatologic Surgery 

Education & Training

  • B.S., Cornell University
  • M.D., UCLA/SUNY Buffalo
  • Ph.D., California Institute of Technology
  • Post Doctoral Fellowship, UCLA
  • Residency, Dermatology, University of Pittsburgh

Representative Publications

Dr. Bunimovich’s publications can be reviewed at the National Library of Medicine’s public database. 

Research Interests

The goal of Dr. Bunimovich’s research program is to investigate the mechanisms of tumorigenesis and immune escape of melanoma and non-melanoma skin cancer (NMSC). The major effort is centered on the development of new medical technologies and therapeutics for cutaneous malignancies. In close collaboration with immunologists, chemists and other clinicians, Dr. Bunimovich is developing novel topical immunotherapy to treat high risk primary melanoma and NMSC. He is also investigating the factors leading to cutaneous microenvironment which supports tumor initiation and progression.